Dr Peter Timmerman | Chief Scientific Officer
Pepscan Therapeutics

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics

Peter Timmerman joined Pepscan in 2001 and is responsible for scientific developments at Pepscan and in his role as CSO drives further advances in protein mimicry for peptide drug discovery program. He is inventor of the CLIPS technology and also holds a chair as Professor (by special appointment) in Protein Mimetic Chemistry at the University of Amsterdam. He studied Chemistry at the Vrije Universiteit (Amsterdam), and obtained his PhD summa cum laude from the University of Twente. In 1995, he was recipient of the Backer Prize for the best thesis in Organic Chemistry. He did post-doctoral research at the ETH in Zürich and was Assistant Professor in Supramolecular Chemistry and Technology at the University of Twente from 1995-2001. He is co-author of over 80 scientific papers and co-inventor on >10 patents.

Appearances:



Day One 10th Oct Human, Vet, Immune @ 12:45

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

back to speakers